Critical Care of Spinal Cord Injury

Curr Neurol Neurosci Rep. 2024 Sep;24(9):355-363. doi: 10.1007/s11910-024-01357-8. Epub 2024 Jul 15.

Abstract

Purpose of review: Spinal cord injury (SCI) is a major cause of morbidity and mortality, posing a significant financial burden on patients and the healthcare system. While little can be done to reverse the primary mechanical insult, minimizing secondary injury due to ischemia and inflammation and avoiding complications that adversely affect neurologic outcome represent major goals of management. This article reviews important considerations in the acute critical care management of SCI to improve outcomes.

Recent findings: Neuroprotective agents, such as riluzole, may allow for improved neurologic recovery but require further investigation at this time. Various forms of neuromodulation, such as transcranial magnetic stimulation, are currently under investigation. Early decompression and stabilization of SCI is recommended within 24 h of injury when indicated. Spinal cord perfusion may be optimized with a mean arterial pressure goal from a lower limit of 75-80 to an upper limit of 90-95 mmHg for 3-7 days after injury. The use of corticosteroids remains controversial; however, initiation of a 24-h infusion of methylprednisolone 5.4 mg/kg/hour within 8 h of injury has been found to improve motor scores. Attentive pulmonary and urologic care along with early mobilization can reduce in-hospital complications.

Keywords: Corticosteroids; Critical care; Riluzole; Spinal cord injury; Spinal cord perfusion.

Publication types

  • Review

MeSH terms

  • Critical Care* / methods
  • Humans
  • Neuroprotective Agents / therapeutic use
  • Spinal Cord Injuries* / therapy

Substances

  • Neuroprotective Agents